Bank of New York Mellon Corp - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 89 filers reported holding SPERO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$11,000
-98.3%
14,966
-79.5%
0.00%
Q1 2022$636,000
-47.0%
73,070
-2.6%
0.00%
Q4 2021$1,200,000
-12.2%
75,000
+1.1%
0.00%
Q3 2021$1,366,000
+46.9%
74,207
+11.4%
0.00%
Q2 2021$930,000
-0.1%
66,595
+5.4%
0.00%
Q1 2021$931,000
-31.3%
63,172
-9.6%
0.00%
Q4 2020$1,355,000
+135.7%
69,883
+35.6%
0.00%
Q3 2020$575,000
-14.9%
51,526
+3.2%
0.00%
Q2 2020$676,000
+82.2%
49,937
+8.4%
0.00%
Q1 2020$371,000
+2.2%
46,064
+21.9%
0.00%
Q4 2019$363,000
-8.1%
37,774
+1.5%
0.00%
Q3 2019$395,0000.0%37,223
+8.6%
0.00%
Q2 2019$395,000
-8.1%
34,279
+2.1%
0.00%
Q1 2019$430,000
+90.3%
33,571
-8.6%
0.00%
Q4 2018$226,000
-22.9%
36,716
+31.9%
0.00%
Q3 2018$293,000
-19.3%
27,828
+12.7%
0.00%
Q2 2018$363,000
+79.7%
24,689
+73.9%
0.00%
Q1 2018$202,00014,1990.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,353,303$1,637,49713.93%
Anson Funds Management LP 4,159,572$5,033,0821.01%
OUP Management Co., LLC 249,070$301,3750.68%
Atlas Venture Life Science Advisors, LLC 1,013,438$1,226,2600.19%
Murchinson Ltd. 862,700$1,043,8670.13%
Alphabet Inc. 889,979$1,076,8740.07%
AWM Investment Company, Inc. 333,400$403,4140.06%
DAFNA Capital Management LLC 125,000$151,2500.05%
Novo Holdings A/S 468,902$567,3710.04%
XTX Topco Ltd 58,368$70,6250.01%
View complete list of SPERO THERAPEUTICS INC shareholders